- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Outcome of MS relapses in the era of disease-modifying therapy ; volume:17 ; number:1 ; day:7 ; month:8 ; year:2017 ; pages:1-8 ; date:12.2017
BMC neurology ; 17, Heft 1 (7.8.2017), 1-8, 12.2017
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Stoppe, Muriel
- Beteiligte Personen und Organisationen
-
Busch, Maria
Krizek, Luise
Then Bergh, Florian
SpringerLink (Online service)
- DOI
-
10.1186/s12883-017-0927-x
- URN
-
urn:nbn:de:1111-2017081711909
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stoppe, Muriel
- Busch, Maria
- Krizek, Luise
- Then Bergh, Florian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Current Disease-Modifying Therapies in Multiple Sclerosis
Disease-modifying treatments in Alzheimer’s disease
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Lithium as a disease-modifying agent for prion diseases
Current experimental disease-modifying therapeutics for multiple system atrophy
Jellyfish mucin may have potential disease-modifying effects on osteoarthritis
Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
Disease-modifying effects of ranibizumab for central retinal vein occlusion
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis
Disease-modifying factors in hereditary angioedema: an RNA expression-based screening
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Current Disease-Modifying Therapies in Multiple Sclerosis
Disease-modifying treatments in Alzheimer’s disease
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Lithium as a disease-modifying agent for prion diseases
Current experimental disease-modifying therapeutics for multiple system atrophy
Jellyfish mucin may have potential disease-modifying effects on osteoarthritis
Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
Disease-modifying effects of ranibizumab for central retinal vein occlusion
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis
Disease-modifying factors in hereditary angioedema: an RNA expression-based screening
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Current Disease-Modifying Therapies in Multiple Sclerosis
Disease-modifying treatments in Alzheimer’s disease
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Lithium as a disease-modifying agent for prion diseases
Current experimental disease-modifying therapeutics for multiple system atrophy
Jellyfish mucin may have potential disease-modifying effects on osteoarthritis
Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
Disease-modifying effects of ranibizumab for central retinal vein occlusion
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis
Disease-modifying factors in hereditary angioedema: an RNA expression-based screening